SCHEMBL23090375

SCHEMBL23090375

COc1cc2c(cc1C(=O)Nc1cc(C(C)(C)C)[nH]n1)CCCCC2

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.59
▸ STK25 O00506 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RAB9A P51151 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MAPK14 Q16539 1/20 0.39
▸ CNR2 P34972 1/20 0.38
▸ ALPL P05186 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ BRAF P15056 1/20 0.37
▸ ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23090415 0.80 MEN1 (0.62) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090412 0.77 DHODH (0.71) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090376 0.75 DHODH (0.55) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090382 0.74 DHODH (1.00) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090406 0.72 DHODH (0.58) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090394 0.72 DHODH (0.58) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23651305 0.72 DHODH (0.77) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL23090367 0.71 DHODH (1.00) DHODHALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL10985695 0.71 STK25 (0.52) STK25MAPK14CNR2BRAF
SCHEMBL23090368 0.68 DHODH (0.53) DHODHALDH1A1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-11066357-B2 Benzoannulene derivatives as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2021-07-20 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078937-A1 BENZOANNULENE DERIVATIVES AS ANTIVIRAL AGENTS ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885STK25 1358/4885ALDH1A1 844/4885
US-11066357-B2 Benzoannulene derivatives as antiviral agents ZC3HAV1, MAVS, ZC3HAV1L DHODH 344/4885STK25 1358/4885ALDH1A1 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback